-+ 0.00%
-+ 0.00%
-+ 0.00%

BREAKTHROUGH T1D AWARDS GRANT TO SUPPORT PRISE‑HATG STUDY OF SAB‑142 IN STAGE 3 TYPE 1 DIABETES

Reuters·07/07/2026 12:07:57

Please log in to view news